Table of Content

1 Study Coverage
1.1 Mumps Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Mumps Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Child
1.2.3 Adult
1.3 Market by Application
1.3.1 Global Mumps Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Mumps Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Mumps Vaccine Revenue by Region
2.2.1 Global Mumps Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Mumps Vaccine Revenue by Region (2018-2024)
2.2.3 Global Mumps Vaccine Revenue by Region (2024-2029)
2.2.4 Global Mumps Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Mumps Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Mumps Vaccine Sales by Region
2.4.1 Global Mumps Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Mumps Vaccine Sales by Region (2018-2024)
2.4.3 Global Mumps Vaccine Sales by Region (2024-2029)
2.4.4 Global Mumps Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Mumps Vaccine Sales by Manufacturers
3.1.1 Global Mumps Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Mumps Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Mumps Vaccine in 2022
3.2 Global Mumps Vaccine Revenue by Manufacturers
3.2.1 Global Mumps Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Mumps Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Mumps Vaccine Revenue in 2022
3.3 Global Key Players of Mumps Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Mumps Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Mumps Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Mumps Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Mumps Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Mumps Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Mumps Vaccine Sales by Type
4.1.1 Global Mumps Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Mumps Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Mumps Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Mumps Vaccine Revenue by Type
4.2.1 Global Mumps Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Mumps Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Mumps Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Mumps Vaccine Price by Type
4.3.1 Global Mumps Vaccine Price by Type (2018-2024)
4.3.2 Global Mumps Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Mumps Vaccine Sales by Application
5.1.1 Global Mumps Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Mumps Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Mumps Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Mumps Vaccine Revenue by Application
5.2.1 Global Mumps Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Mumps Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Mumps Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Mumps Vaccine Price by Application
5.3.1 Global Mumps Vaccine Price by Application (2018-2024)
5.3.2 Global Mumps Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Mumps Vaccine Market Size by Type
6.1.1 US & Canada Mumps Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Mumps Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Mumps Vaccine Market Size by Application
6.2.1 US & Canada Mumps Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Mumps Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Mumps Vaccine Market Size by Country
6.3.1 US & Canada Mumps Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Mumps Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Mumps Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Mumps Vaccine Market Size by Type
7.1.1 Europe Mumps Vaccine Sales by Type (2018-2029)
7.1.2 Europe Mumps Vaccine Revenue by Type (2018-2029)
7.2 Europe Mumps Vaccine Market Size by Application
7.2.1 Europe Mumps Vaccine Sales by Application (2018-2029)
7.2.2 Europe Mumps Vaccine Revenue by Application (2018-2029)
7.3 Europe Mumps Vaccine Market Size by Country
7.3.1 Europe Mumps Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Mumps Vaccine Sales by Country (2018-2029)
7.3.3 Europe Mumps Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Mumps Vaccine Market Size
8.1.1 China Mumps Vaccine Sales (2018-2029)
8.1.2 China Mumps Vaccine Revenue (2018-2029)
8.2 China Mumps Vaccine Market Size by Application
8.2.1 China Mumps Vaccine Sales by Application (2018-2029)
8.2.2 China Mumps Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Mumps Vaccine Market Size by Type
9.1.1 Asia Mumps Vaccine Sales by Type (2018-2029)
9.1.2 Asia Mumps Vaccine Revenue by Type (2018-2029)
9.2 Asia Mumps Vaccine Market Size by Application
9.2.1 Asia Mumps Vaccine Sales by Application (2018-2029)
9.2.2 Asia Mumps Vaccine Revenue by Application (2018-2029)
9.3 Asia Mumps Vaccine Sales by Region
9.3.1 Asia Mumps Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Mumps Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Mumps Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Mumps Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Mumps Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Mumps Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Mumps Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Mumps Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Mumps Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Mumps Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Mumps Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Mumps Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Mumps Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 MedImmune
11.1.1 MedImmune Company Information
11.1.2 MedImmune Overview
11.1.3 MedImmune Mumps Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 MedImmune Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 MedImmune Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Overview
11.2.3 Johnson & Johnson Mumps Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Johnson & Johnson Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Johnson & Johnson Recent Developments
11.3 Merck & Co., Inc.
11.3.1 Merck & Co., Inc. Company Information
11.3.2 Merck & Co., Inc. Overview
11.3.3 Merck & Co., Inc. Mumps Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Merck & Co., Inc. Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck & Co., Inc. Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Mumps Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Sanofi Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Recent Developments
11.5 Serum Institute of India
11.5.1 Serum Institute of India Company Information
11.5.2 Serum Institute of India Overview
11.5.3 Serum Institute of India Mumps Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Serum Institute of India Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Serum Institute of India Recent Developments
11.6 Bavarian Nordic
11.6.1 Bavarian Nordic Company Information
11.6.2 Bavarian Nordic Overview
11.6.3 Bavarian Nordic Mumps Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Bavarian Nordic Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bavarian Nordic Recent Developments
11.7 Astellas Pharma India
11.7.1 Astellas Pharma India Company Information
11.7.2 Astellas Pharma India Overview
11.7.3 Astellas Pharma India Mumps Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Astellas Pharma India Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Astellas Pharma India Recent Developments
11.8 CSL Limited
11.8.1 CSL Limited Company Information
11.8.2 CSL Limited Overview
11.8.3 CSL Limited Mumps Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 CSL Limited Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 CSL Limited Recent Developments
11.9 Emergent BioSolutions
11.9.1 Emergent BioSolutions Company Information
11.9.2 Emergent BioSolutions Overview
11.9.3 Emergent BioSolutions Mumps Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Emergent BioSolutions Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Emergent BioSolutions Recent Developments
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Information
11.10.2 GlaxoSmithKline Overview
11.10.3 GlaxoSmithKline Mumps Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 GlaxoSmithKline Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 GlaxoSmithKline Recent Developments
11.11 Panacea Biotec, Ltd.
11.11.1 Panacea Biotec, Ltd. Company Information
11.11.2 Panacea Biotec, Ltd. Overview
11.11.3 Panacea Biotec, Ltd. Mumps Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Panacea Biotec, Ltd. Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Panacea Biotec, Ltd. Recent Developments
11.12 Biological E Limited
11.12.1 Biological E Limited Company Information
11.12.2 Biological E Limited Overview
11.12.3 Biological E Limited Mumps Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Biological E Limited Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Biological E Limited Recent Developments
11.13 Bharat Biotech Ltd.
11.13.1 Bharat Biotech Ltd. Company Information
11.13.2 Bharat Biotech Ltd. Overview
11.13.3 Bharat Biotech Ltd. Mumps Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Bharat Biotech Ltd. Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Bharat Biotech Ltd. Recent Developments
11.14 Novavax, Inc.
11.14.1 Novavax, Inc. Company Information
11.14.2 Novavax, Inc. Overview
11.14.3 Novavax, Inc. Mumps Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Novavax, Inc. Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Novavax, Inc. Recent Developments
11.15 Novartis
11.15.1 Novartis Company Information
11.15.2 Novartis Overview
11.15.3 Novartis Mumps Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Novartis Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Novartis Recent Developments
11.16 Sinovac Biotech, Ltd.
11.16.1 Sinovac Biotech, Ltd. Company Information
11.16.2 Sinovac Biotech, Ltd. Overview
11.16.3 Sinovac Biotech, Ltd. Mumps Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Sinovac Biotech, Ltd. Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Sinovac Biotech, Ltd. Recent Developments
11.17 Incepta Vaccine Limited
11.17.1 Incepta Vaccine Limited Company Information
11.17.2 Incepta Vaccine Limited Overview
11.17.3 Incepta Vaccine Limited Mumps Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Incepta Vaccine Limited Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Incepta Vaccine Limited Recent Developments
11.18 Valneva SE
11.18.1 Valneva SE Company Information
11.18.2 Valneva SE Overview
11.18.3 Valneva SE Mumps Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 Valneva SE Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Valneva SE Recent Developments
11.19 VBI Vaccines
11.19.1 VBI Vaccines Company Information
11.19.2 VBI Vaccines Overview
11.19.3 VBI Vaccines Mumps Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.19.4 VBI Vaccines Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 VBI Vaccines Recent Developments
11.20 PT Bio Farma
11.20.1 PT Bio Farma Company Information
11.20.2 PT Bio Farma Overview
11.20.3 PT Bio Farma Mumps Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.20.4 PT Bio Farma Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 PT Bio Farma Recent Developments
11.21 Sharp & Dohme Corp
11.21.1 Sharp & Dohme Corp Company Information
11.21.2 Sharp & Dohme Corp Overview
11.21.3 Sharp & Dohme Corp Mumps Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.21.4 Sharp & Dohme Corp Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Sharp & Dohme Corp Recent Developments
11.22 Bionity
11.22.1 Bionity Company Information
11.22.2 Bionity Overview
11.22.3 Bionity Mumps Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.22.4 Bionity Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Bionity Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Mumps Vaccine Industry Chain Analysis
12.2 Mumps Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Mumps Vaccine Production Mode & Process
12.4 Mumps Vaccine Sales and Marketing
12.4.1 Mumps Vaccine Sales Channels
12.4.2 Mumps Vaccine Distributors
12.5 Mumps Vaccine Customers
13 Market Dynamics
13.1 Mumps Vaccine Industry Trends
13.2 Mumps Vaccine Market Drivers
13.3 Mumps Vaccine Market Challenges
13.4 Mumps Vaccine Market Restraints
14 Key Findings in The Global Mumps Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Mumps Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Child
Table 3. Major Manufacturers of Adult
Table 4. Global Mumps Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Mumps Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Mumps Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Mumps Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Mumps Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global Mumps Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Mumps Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Mumps Vaccine Sales by Region (2018-2024) & (K Units)
Table 12. Global Mumps Vaccine Sales by Region (2024-2029) & (K Units)
Table 13. Global Mumps Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global Mumps Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Mumps Vaccine Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Mumps Vaccine Sales Share by Manufacturers (2018-2024)
Table 17. Global Mumps Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Mumps Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Mumps Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Mumps Vaccine Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Mumps Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Mumps Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mumps Vaccine as of 2022)
Table 23. Global Key Manufacturers of Mumps Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Mumps Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Mumps Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Mumps Vaccine Sales by Type (2018-2024) & (K Units)
Table 28. Global Mumps Vaccine Sales by Type (2024-2029) & (K Units)
Table 29. Global Mumps Vaccine Sales Share by Type (2018-2024)
Table 30. Global Mumps Vaccine Sales Share by Type (2024-2029)
Table 31. Global Mumps Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Mumps Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Mumps Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Mumps Vaccine Revenue Share by Type (2024-2029)
Table 35. Mumps Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Mumps Vaccine Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Mumps Vaccine Sales by Application (2018-2024) & (K Units)
Table 38. Global Mumps Vaccine Sales by Application (2024-2029) & (K Units)
Table 39. Global Mumps Vaccine Sales Share by Application (2018-2024)
Table 40. Global Mumps Vaccine Sales Share by Application (2024-2029)
Table 41. Global Mumps Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Mumps Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Mumps Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Mumps Vaccine Revenue Share by Application (2024-2029)
Table 45. Mumps Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Mumps Vaccine Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Mumps Vaccine Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Mumps Vaccine Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Mumps Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Mumps Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Mumps Vaccine Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Mumps Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Mumps Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Mumps Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Mumps Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Mumps Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Mumps Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Mumps Vaccine Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Mumps Vaccine Sales by Country (2024-2029) & (K Units)
Table 60. Europe Mumps Vaccine Sales by Type (2018-2024) & (K Units)
Table 61. Europe Mumps Vaccine Sales by Type (2024-2029) & (K Units)
Table 62. Europe Mumps Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Mumps Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Mumps Vaccine Sales by Application (2018-2024) & (K Units)
Table 65. Europe Mumps Vaccine Sales by Application (2024-2029) & (K Units)
Table 66. Europe Mumps Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Mumps Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Mumps Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Mumps Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Mumps Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Mumps Vaccine Sales by Country (2018-2024) & (K Units)
Table 72. Europe Mumps Vaccine Sales by Country (2024-2029) & (K Units)
Table 73. China Mumps Vaccine Sales by Type (2018-2024) & (K Units)
Table 74. China Mumps Vaccine Sales by Type (2024-2029) & (K Units)
Table 75. China Mumps Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Mumps Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Mumps Vaccine Sales by Application (2018-2024) & (K Units)
Table 78. China Mumps Vaccine Sales by Application (2024-2029) & (K Units)
Table 79. China Mumps Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Mumps Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Mumps Vaccine Sales by Type (2018-2024) & (K Units)
Table 82. Asia Mumps Vaccine Sales by Type (2024-2029) & (K Units)
Table 83. Asia Mumps Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Mumps Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Mumps Vaccine Sales by Application (2018-2024) & (K Units)
Table 86. Asia Mumps Vaccine Sales by Application (2024-2029) & (K Units)
Table 87. Asia Mumps Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Mumps Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Mumps Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Mumps Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Mumps Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Mumps Vaccine Sales by Region (2018-2024) & (K Units)
Table 93. Asia Mumps Vaccine Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Mumps Vaccine Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Mumps Vaccine Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Mumps Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Mumps Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Mumps Vaccine Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Mumps Vaccine Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Mumps Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Mumps Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Mumps Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Mumps Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Mumps Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Mumps Vaccine Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Mumps Vaccine Sales by Country (2024-2029) & (K Units)
Table 107. MedImmune Company Information
Table 108. MedImmune Description and Major Businesses
Table 109. MedImmune Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. MedImmune Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. MedImmune Recent Developments
Table 112. Johnson & Johnson Company Information
Table 113. Johnson & Johnson Description and Major Businesses
Table 114. Johnson & Johnson Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Johnson & Johnson Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Johnson & Johnson Recent Developments
Table 117. Merck & Co., Inc. Company Information
Table 118. Merck & Co., Inc. Description and Major Businesses
Table 119. Merck & Co., Inc. Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Merck & Co., Inc. Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Merck & Co., Inc. Recent Developments
Table 122. Sanofi Company Information
Table 123. Sanofi Description and Major Businesses
Table 124. Sanofi Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Sanofi Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Sanofi Recent Developments
Table 127. Serum Institute of India Company Information
Table 128. Serum Institute of India Description and Major Businesses
Table 129. Serum Institute of India Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Serum Institute of India Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Serum Institute of India Recent Developments
Table 132. Bavarian Nordic Company Information
Table 133. Bavarian Nordic Description and Major Businesses
Table 134. Bavarian Nordic Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Bavarian Nordic Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Bavarian Nordic Recent Developments
Table 137. Astellas Pharma India Company Information
Table 138. Astellas Pharma India Description and Major Businesses
Table 139. Astellas Pharma India Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Astellas Pharma India Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Astellas Pharma India Recent Developments
Table 142. CSL Limited Company Information
Table 143. CSL Limited Description and Major Businesses
Table 144. CSL Limited Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. CSL Limited Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. CSL Limited Recent Developments
Table 147. Emergent BioSolutions Company Information
Table 148. Emergent BioSolutions Description and Major Businesses
Table 149. Emergent BioSolutions Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Emergent BioSolutions Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Emergent BioSolutions Recent Developments
Table 152. GlaxoSmithKline Company Information
Table 153. GlaxoSmithKline Description and Major Businesses
Table 154. GlaxoSmithKline Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. GlaxoSmithKline Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. GlaxoSmithKline Recent Developments
Table 157. Panacea Biotec, Ltd. Company Information
Table 158. Panacea Biotec, Ltd. Description and Major Businesses
Table 159. Panacea Biotec, Ltd. Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Panacea Biotec, Ltd. Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Panacea Biotec, Ltd. Recent Developments
Table 162. Biological E Limited Company Information
Table 163. Biological E Limited Description and Major Businesses
Table 164. Biological E Limited Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Biological E Limited Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Biological E Limited Recent Developments
Table 167. Bharat Biotech Ltd. Company Information
Table 168. Bharat Biotech Ltd. Description and Major Businesses
Table 169. Bharat Biotech Ltd. Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Bharat Biotech Ltd. Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Bharat Biotech Ltd. Recent Developments
Table 172. Novavax, Inc. Company Information
Table 173. Novavax, Inc. Description and Major Businesses
Table 174. Novavax, Inc. Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Novavax, Inc. Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Novavax, Inc. Recent Developments
Table 177. Novartis Company Information
Table 178. Novartis Description and Major Businesses
Table 179. Novartis Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Novartis Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Novartis Recent Developments
Table 182. Sinovac Biotech, Ltd. Company Information
Table 183. Sinovac Biotech, Ltd. Description and Major Businesses
Table 184. Sinovac Biotech, Ltd. Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 185. Sinovac Biotech, Ltd. Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Sinovac Biotech, Ltd. Recent Developments
Table 187. Incepta Vaccine Limited Company Information
Table 188. Incepta Vaccine Limited Description and Major Businesses
Table 189. Incepta Vaccine Limited Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 190. Incepta Vaccine Limited Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Incepta Vaccine Limited Recent Developments
Table 192. Valneva SE Company Information
Table 193. Valneva SE Description and Major Businesses
Table 194. Valneva SE Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 195. Valneva SE Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. Valneva SE Recent Developments
Table 197. VBI Vaccines Company Information
Table 198. VBI Vaccines Description and Major Businesses
Table 199. VBI Vaccines Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 200. VBI Vaccines Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 201. VBI Vaccines Recent Developments
Table 202. PT Bio Farma Company Information
Table 203. PT Bio Farma Description and Major Businesses
Table 204. PT Bio Farma Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 205. PT Bio Farma Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 206. PT Bio Farma Recent Developments
Table 207. Sharp & Dohme Corp Company Information
Table 208. Sharp & Dohme Corp Description and Major Businesses
Table 209. Sharp & Dohme Corp Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 210. Sharp & Dohme Corp Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 211. Sharp & Dohme Corp Recent Developments
Table 212. Bionity Company Information
Table 213. Bionity Description and Major Businesses
Table 214. Bionity Mumps Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 215. Bionity Mumps Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 216. Bionity Recent Developments
Table 217. Key Raw Materials Lists
Table 218. Raw Materials Key Suppliers Lists
Table 219. Mumps Vaccine Distributors List
Table 220. Mumps Vaccine Customers List
Table 221. Mumps Vaccine Market Trends
Table 222. Mumps Vaccine Market Drivers
Table 223. Mumps Vaccine Market Challenges
Table 224. Mumps Vaccine Market Restraints
Table 225. Research Programs/Design for This Report
Table 226. Key Data Information from Secondary Sources
Table 227. Key Data Information from Primary Sources
List of Figures
Figure 1. Mumps Vaccine Product Picture
Figure 2. Global Mumps Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Mumps Vaccine Market Share by Type in 2022 & 2029
Figure 4. Child Product Picture
Figure 5. Adult Product Picture
Figure 6. Global Mumps Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Mumps Vaccine Market Share by Application in 2022 & 2029
Figure 8. Hospitals Pharmacies
Figure 9. Retail Pharmacies
Figure 10. Mumps Vaccine Report Years Considered
Figure 11. Global Mumps Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Mumps Vaccine Revenue 2018-2029 (US$ Million)
Figure 13. Global Mumps Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Mumps Vaccine Revenue Market Share by Region (2018-2029)
Figure 15. Global Mumps Vaccine Sales 2018-2029 ((K Units)
Figure 16. Global Mumps Vaccine Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Mumps Vaccine Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Mumps Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Mumps Vaccine Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Mumps Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Mumps Vaccine Sales YoY (2018-2029) & (K Units)
Figure 22. China Mumps Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Mumps Vaccine Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Mumps Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Mumps Vaccine Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Mumps Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Mumps Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Mumps Vaccine in the World: Market Share by Mumps Vaccine Revenue in 2022
Figure 29. Global Mumps Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Mumps Vaccine Sales Market Share by Type (2018-2029)
Figure 31. Global Mumps Vaccine Revenue Market Share by Type (2018-2029)
Figure 32. Global Mumps Vaccine Sales Market Share by Application (2018-2029)
Figure 33. Global Mumps Vaccine Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Mumps Vaccine Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Mumps Vaccine Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Mumps Vaccine Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Mumps Vaccine Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Mumps Vaccine Revenue Share by Country (2018-2029)
Figure 39. US & Canada Mumps Vaccine Sales Share by Country (2018-2029)
Figure 40. U.S. Mumps Vaccine Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Mumps Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Mumps Vaccine Sales Market Share by Type (2018-2029)
Figure 43. Europe Mumps Vaccine Revenue Market Share by Type (2018-2029)
Figure 44. Europe Mumps Vaccine Sales Market Share by Application (2018-2029)
Figure 45. Europe Mumps Vaccine Revenue Market Share by Application (2018-2029)
Figure 46. Europe Mumps Vaccine Revenue Share by Country (2018-2029)
Figure 47. Europe Mumps Vaccine Sales Share by Country (2018-2029)
Figure 48. Germany Mumps Vaccine Revenue (2018-2029) & (US$ Million)
Figure 49. France Mumps Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Mumps Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Mumps Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Mumps Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. China Mumps Vaccine Sales Market Share by Type (2018-2029)
Figure 54. China Mumps Vaccine Revenue Market Share by Type (2018-2029)
Figure 55. China Mumps Vaccine Sales Market Share by Application (2018-2029)
Figure 56. China Mumps Vaccine Revenue Market Share by Application (2018-2029)
Figure 57. Asia Mumps Vaccine Sales Market Share by Type (2018-2029)
Figure 58. Asia Mumps Vaccine Revenue Market Share by Type (2018-2029)
Figure 59. Asia Mumps Vaccine Sales Market Share by Application (2018-2029)
Figure 60. Asia Mumps Vaccine Revenue Market Share by Application (2018-2029)
Figure 61. Asia Mumps Vaccine Revenue Share by Region (2018-2029)
Figure 62. Asia Mumps Vaccine Sales Share by Region (2018-2029)
Figure 63. Japan Mumps Vaccine Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Mumps Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Mumps Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Mumps Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. India Mumps Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Mumps Vaccine Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Mumps Vaccine Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Mumps Vaccine Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Mumps Vaccine Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Mumps Vaccine Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Mumps Vaccine Sales Share by Country (2018-2029)
Figure 74. Brazil Mumps Vaccine Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Mumps Vaccine Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Mumps Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Mumps Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Mumps Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. Mumps Vaccine Value Chain
Figure 80. Mumps Vaccine Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed